Polygenic Risk Identifies Older Adults Who May Benefit From Aspirin for the Primary Prevention of Ischemic Stroke
Stroke · 2026-07 · 57 (7) · 2098-2107
DOI: 10.1161/strokeaha.125.054979 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Stroke, 2026-07. Verfasst von Chenglong Yu und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health and Preventive Medicine (C.Y., S.M.H., P.D.F., C.T., A.M.T., M.R.N., C.M.R., J.T.N., J.J.M., P.L.), Monash University, Melbou…. Hauptthemen laut MEDLINE: Aspirin, Ischemic Stroke, Primary Prevention, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Themen: Gerontologische Pflege, Schlaganfall
Abstract (Originalsprache)
BACKGROUND: Low-dose aspirin is no longer recommended for routine primary prevention in older adults due to bleeding risks outweighing vascular benefits. We hypothesized that an integrative polygenic score (iPGS) could identify a subgroup of older individuals who derive net benefit from aspirin for the primary prevention of ischemic stroke. METHODS: We performed post hoc analysis of the ASPREE randomized, placebo-controlled trial (Aspirin in Reducing Events in the Elderly) of daily 100-mg aspirin, in 12 031 genotyped participants of European ancestry aged >70 years without prior cardiovascular disease. The iPGS was derived from >1.2 million variants and evaluated both continuously and by quintiles. Cox models assessed associations between polygenic risk, ischemic stroke, and major bleeding events, and tested the interaction between the iPGS and treatment allocation, with adjustment for baseline lifestyle and clinical covariates. RESULTS: The mean age of participants was 75.1 years, and 54.9% were women. Over a median of 4.6 years, 187 ischemic strokes and 373 major bleeds occurred, including 101 intracranial bleeds (46 hemorrhagic strokes). Each 1-SD increase in the iPGS was associated with higher incident ischemic stroke risk (hazard ratio, 1.39 [95% CI, 1.20–1.62]). An interaction between the continuous iPGS and aspirin allocation was observed for ischemic stroke ( P =0.04) but not major bleeding. In the highest iPGS quintile, aspirin reduced ischemic stroke by 51% (hazard ratio, 0.49 [95% CI, 0.28–0.85]) without significantly increasing major bleeding (hazard ratio, 1.15 [95% CI, 0.71–1.88]). No benefit was observed in the overall cohort or in lower-risk quintiles. CONCLUSIONS: Among older adults, high polygenic risk identifies individuals who may experience substantial stroke reduction with aspirin, with no excess bleeding. These findings raise the possibility that genomic risk stratification may enable targeted aspirin use for the primary prevention of ischemic stroke. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01038583.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health and Preventive Medicine (C.Y., S.M.H., P.D.F., C.T., A.M.T., M.R.N., C.M.R., J.T.N., J.J.M., P.L.), Monash University, Melbourne, Victoria, Australia.
- Victorian Heart Institute (C.Y.), Monash University, Melbourne, Victoria, Australia.
- Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia (M.R.N.).
- School of Population Health, Curtin University, Perth, Western Australia, Australia (C.M.R.).
- Department of Cardiology, University Heart and Vascular Center, University Medical Center Hamburg-Eppendorf, Germany (J.T.N.).
- German Center for Cardiovascular Research (DZHK), Hamburg, Germany (J.T.N.).
ORCID-Profile: Chenglong Yu, Sultana Monira Hussain, Peter D Fransquet, Cammie Tran, Andrew M Tonkin, Mark R Nelson, Christopher M Reid, Johannes T Neumann, Charles B Eaton, Geoffrey A Donnan, Amy Brodtmann, Geoffrey C Cloud, John J McNeil, Paul Lacaze
Förderung
- NIA NIH HHS
Zitieren
APA
Yu, C., Hussain, S. M., Fransquet, P. D., Tran, C., Tonkin, A. M., Nelson, M. R., Reid, C. M., Neumann, J. T., Williamson, J. D., Eaton, C. B., Hand, P., Donnan, G. A., Brodtmann, A., Cloud, G. C., McNeil, J. J., & Lacaze, P. (2026). Polygenic Risk Identifies Older Adults Who May Benefit From Aspirin for the Primary Prevention of Ischemic Stroke. Stroke, 57(7), 2098-2107. https://doi.org/10.1161/strokeaha.125.054979
Vancouver
Yu C, Hussain SM, Fransquet PD, Tran C, Tonkin AM, Nelson MR, et al. Polygenic Risk Identifies Older Adults Who May Benefit From Aspirin for the Primary Prevention of Ischemic Stroke. Stroke. 2026;57(7):2098-2107. doi:10.1161/strokeaha.125.054979
BibTeX
@article{Yu2026,
author = {Yu, Chenglong and Hussain, Sultana Monira and Fransquet, Peter D and Tran, Cammie and Tonkin, Andrew M and Nelson, Mark R and Reid, Christopher M and Neumann, Johannes T and Williamson, Jeff D and Eaton, Charles B and Hand, Peter and Donnan, Geoffrey A and Brodtmann, Amy and Cloud, Geoffrey C and McNeil, John J and Lacaze, Paul},
title = {Polygenic Risk Identifies Older Adults Who May Benefit From Aspirin for the Primary Prevention of Ischemic Stroke},
journal = {Stroke},
year = {2026},
volume = {57},
number = {7},
pages = {2098--2107},
doi = {10.1161/strokeaha.125.054979}
}
EUVIMED